Literature DB >> 3360681

Effects of quinolones on mitogen-stimulated human mononuclear leucocytes.

J P Manzella1, J K Clark.   

Abstract

The effects of several quinolone compounds on mitogen-stimulation of normal human mononuclear leucocytes were studied. In these experiments, mononuclear leucocytes were obtained from heparinized whole blood of healthy young adult donors by Ficoll-hypaque sedimentation. The cells were cultured in the presence of both mitogen and various concentrations of the quinolone compounds. Control cultures (without the addition of the quinolones) were examined concurrently. Our data suggests that the quinolones tested, with the exception of rosoxacin (acrosoxacin) at a concentration of 2.5 mg/l, neither impair nor stimulate activation of lymphocytes by the mitogen phytohaemagglutinin (PHA) when used at the concentrations obtained during therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3360681     DOI: 10.1093/jac/21.2.183

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Selective enhancement of synthesis of interleukin-2 in lymphocytes in the presence of ciprofloxacin.

Authors:  K Riesbeck; A Forsgren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

2.  Influence of two quinolones, ofloxacin and pefloxacin, on human myelopoiesis in vitro.

Authors:  F Pallavicini; A Antinori; G Federico; M Fantoni; P Nervo
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

Review 3.  Immunomodulating effects of antibiotics: literature review.

Authors:  B Van Vlem; R Vanholder; P De Paepe; D Vogelaers; S Ringoir
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

4.  Lack of in vitro antiviral activity of fluoroquinolones against herpes simplex virus type 2.

Authors:  A Pessina; E Mineo; L Gribaldo; M G Neri
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.